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Histological Chorioamnionitis
Induces Differential Gene
Expression in Human Cord Blood
Mononuclear Leukocytes from Term
Neonates
Suhita Gayen nee’ Betal1, Swati Murthy1, Michael Favara1, Gina Fong1, Joanna S. Y. Chan2,
Sankar Addya3, Thomas H. Shaffer1, Jay Greenspan1, Vineet Bhandari 4, Irfan Rahman 5 &
Zubair H. Aghai1
Histological chorioamnionitis (HCA) is an infection of fetal membranes and complicates 5.2% to 28.5%
of all live births. HCA is associated with increased mortality and morbidity in both premature and term
neonates. Exposure to HCA may have long-term consequences, including an increased risk for allergic
disorders and asthma later in childhood, the mechanism(s) of which are still not yet well understood.
The objective of this study was to determine the mRNA transcriptome of cord blood mononuclear
leukocytes from term neonates to identify key genes and pathways involved in HCA. We found 366
differentially expressed probe IDs with exposure to HCA (198 upregulated, 168 downregulated). These
transcriptomes included novel genes and pathways associated with exposure to HCA. The differential
gene expression included key genes regulating inflammatory, immune, respiratory and neurological
pathways, which may contribute to disorders in those pathways in neonates exposed to HCA. Our data
may lead to understanding of the role of key genes and pathways identified on the long-term sequelae
related to exposure to HCA, as well as to identifying potential markers and therapies to prevent HCAassociated complications.
Chorioamnionitis (CA) is an infection of the fetal membranes and placenta that complicates 5.2% of all live
births1. The prevalence of histological CA (HCA) in term neonates with spontaneous labor is 23.6–28.7%2,3.
Approximately 500,000 to one million infants in the United States are born each year to mothers diagnosed with
HCA. Exposure to HCA may have long-term consequences, including an increased risk for allergic disorders
and asthma later in childhood4–6. Additionally, studies have demonstrated that exposure to HCA can also lead
to developmental delay and cerebral palsy in preterm and term infants7–9. Asthma and other allergic chronic
diseases during childhood affect greater than 7 million children in the United States10. Although HCA is associated with the development of asthma, allergic disorders, and neurodevelopmental impairment, the exact mechanism for these complications is unknown. Exposure to infection during late fetal life is likely to incite epigenetic
changes, which may modulate the immune and neurological systems and increase the risk for development of
neurological and allergic disorders later in life.
Gene expression studies of cells and tissues have become a major tool for discovery in the pathogenesis of various diseases. Global gene expression by transcriptomic analysis can uncover gene signatures and help delineate
molecular pathways involved in the development of asthma, allergy, and neurodevelopmental impairment in neonates born to mothers with HCA. Previous studies have reported differential gene expression patterns associated
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ProbeID

Gene Symbol

TC17001604.hg.1

LRRC37A4P

TC04002938.hg.1

LOC285505

TC07000288.hg.1

LINC01061

HCA Group
Average Expression
1389.16
364.56
1652

Control Group
Average Expression

Fold
Change

Up/Down

4.01

344.89

P-value
0.0245

136.24

2.68

0.012

643.59

2.58

0.0117

TC03000255.hg.1

CCR2

765.36

304.44

2.51

0.0417

TC04001682.hg.1

FAM198B

643.59

256

2.5

0.0167

TC17000604.hg.1

LRRC37A2

TC07001299.hg.1

Up

13216.02

5556.65

2.37

TRGV4

140.07

60.13

2.32

TC07001300.hg.1

TRGV3

179.77

79.89

2.24

4.50xE-05

TC04002939.hg.1

TMEM144

240.52

112.99

2.12

0.0173

TC17001603.hg.1

LRRC37A4P; LRRC37A2

20594.91

9946.68

2.08

0.0478

TC01003638.hg.1

PTGS2

252.48

9089.59

−35.91

0.0205

TC04002953.hg.1

AREG

TC01001749.hg.1

G0S2

313
2352.53

0.0312
0.0002

1884.54

−6.03

0.001

13034.07

−5.54

0.008

TC05001854.hg.1

HBEGF

385.34

2005.85

−5.18

0.0022

TC19001593.hg.1

PLAUR

1448.15

7082.29

−4.89

0.0138

TC21001069.hg.1

SAMSN1

3956.48

17438.64

−4.42

TC12001216.hg.1

OLR1

178.53

765.36

−4.27

TC03000276.hg.1

CAMP

657.11

2683.69

−4.09

0.0011

TC09000508.hg.1

NR4A3

143.01

580.04

−4.07

0.0128

TC03001357.hg.1

LTF

2683.69

9345.14

−3.49

0.0208

Down

0.0257
0.0365

Table 1. Top 10 differentially up- or down-regulated genes after exposure to HCA.

with preterm labor and lipopolysaccharide (LPS) stimulation of cord blood leukocytes11,12. More recently, differential gene expression in whole blood from preterm neonates exposed to HCA has been published13. However,
fetal inflammatory and immune response to microbial infection differ between preterm (born before 37 weeks
gestation) and term infants14–16. The effects of HCA on gene expression profile on cord blood mononuclear leukocytes in human term neonates have not been characterized. Our objective was to determine the mRNA transcriptome of cord blood mononuclear leukocytes from term neonates and identify key genes and pathways involved
in HCA.

Results

Ten term infants were enrolled in the study. Five infants had histological chorioamnionitis (HCA group), and five
infants with no evidence of histological chorioamnionitis on placental histopathology served as the control group.

Differential Gene Expression.

Comparison of the HCA group array data with the control group using
transcriptome array console software revealed that 366 probe IDs were differentially expressed with a fold
change ≥ 1.5 (p < 0.05). Of these, 198 probe IDs were significantly up-regulated (Supplementary Table 1), 60
with annotated genes and 138 non-annotated genes. One hundred and sixty-eight probe IDs were significantly
down-regulated (Supplementary Table 2), of which 105 had annotation with gene symbols and 63 were not annotated. The top 10 up- and down-regulated genes based on the fold change are reported in Table 1. The top 10
up-regulated genes included chemokine (C-C motif) receptor-2 (CCR2), a pro-inflammatory chemokine important in inflammatory diseases including asthma17,18. The top down-regulated genes included two important antimicrobial proteins, lactoferrin (LTF) and cathelicidin antimicrobial peptide (CAMP).

Differential Gene Expressions Related to Immune Response.

Thirty genes related to immune
response and important for regulation of inflammatory pathways were identified (Table 2). Twelve genes were
up-regulated and 18 genes were down-regulated. The up-regulated genes have been previously associated with
asthma; hyper-reactivity and allergy (CCR2, HRH2, PTEN); lung development and apoptosis (CHRNA7,
RTKN2); and immune function (GIMAP4, GIMAP7, KLRC3 and CD99) (Table 3). Similarly, the down-regulated
genes have roles in asthma and airway modeling (PTGS2, AREG, HBEGF, PLAUR, CAMP, LTF, FCAR,
PDE4B, ZNF331 and IRAK2) and immune function (NR4A3, NFIL3, ADGRE3, TARM1 and ZC3H12A). The
down-regulated gene CXCL1 has a role in lung development and BPD (Table 4).

Ingenuity Pathway Analysis. Pathway analysis was performed using Ingenuity Pathway Analysis (IPA)
software (QIAGEN Inc., https://www.qiagenbioinformatics.com/products/ingenuitypathway-analysis) by loading
366 probe sets that were differentially expressed with HCA19. Seventy-three functions were modified by differential gene expression with exposure to HCA. Important functions modified with the exposure to HCA are listed
in Table 5. The modification of functions with HCA included genes related to immune system, inflammatory
response, connective tissue disorders, neurodevelopmental disorders, hematological development and disorders,
and respiratory development and disorders. Ingenuity Canonical Pathway Analysis identified 207 pathways that
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Gene Symbol

Up/Down

Fold Change

P-value

HCA Group
Average Expression

Control Group
Average Expression

CCR2

2.51

0.0417

765.36

TRGV4

2.32

0.0002

140.07

60.13

GIMAP4

2.29

0.0118

52498.92

23010.42

304.44

TRGV3

2.24

0.000045

179.77

79.89

KLRC3

1.8

0.0433

1458.23

809.00
1002.93

HRH2

1.74

0.0233

1734.13

CHRNA7

1.61

0.0201

33.36

20.68

1.61

0.0086

4482.23

2778.33

GIMAP7

Up-regulated Genes

RTKN2

1.59

0.0294

153.28

96.34

CD99

1.56

0.0121

2646.74

1698.45

PTEN

1.55

0.0275

694.58

448.82

GIMAP1GIMAP5;
GIMAP5;
GIMAP1

1.53

0.0155

989.12

648.07

PTGS2

−35.91

0.0205

252.48

9089.59

AREG

−6.03

0.001

313.00

1884.54

HBEGF

−5.18

0.0022

385.34

2005.85

PLAUR

−4.89

0.0138

1448.15

7082.29
2683.69

CAMP

−4.09

0.0011

657.11

NR4A3

−4.07

0.0128

143.01

580.04

LTF

−3.49

0.0208

2683.69

9345.14

NFIL3

−2.77

0.0262

1192.69

3304.00

FCAR

−2.35

0.0023

2256.70

5330.30

PDE4B

Down-regulated Genes

ADGRE3

−2.33

0.0125

280.14

652.58

−2.3

0.042

680.29

1573.76

CXCL1

−2.05

0.0404

112.21

229.13

TARM1

−2.02

0.0059

116.16

235.57

SNAI1

−1.93

0.0083

47.18

91.14

ZNF331

−1.77

0.0308

288.01

512.00

ZC3H12A

−1.76

0.0422

256.00

451.94

IRAK2

−1.74

0.048

164.28

284.05

NFKBIE

−1.59

0.0351

413.00

657.11

Table 2. Differential expression of genes related to immune response after exposure to HCA.

were modified after exposure to HCA, of which 19 pathways are known to be important in immune regulation
and inflammatory responses (Table 6).

IPA Networks.

IPA picked up important networks related to immune, inflammatory, and neurological pathways. Four were closely related to immune modulation and inflammatory response and two were related to neurologic disease. Networks 1 through 4 are shown in Fig. 1. Network 1 is related to humoral immune response,
protein synthesis, cellular function and maintenance. Network 2 is related to post-translational modification,
cellular development, connective tissue development and function. Network 3 is related to cellular movement, cell
cycle, connective tissue development, and function. Network 4 is related to cellular movement, hematological system development and function, and hematopoiesis. Networks 5 and 6 are closely related to neurological disease
(Fig. 2). Network 5 involves organismal injury and abnormalities, reproductive system disease, and neurological
disease. Network 6 involves dermatological diseases and conditions, organismal injury and abnormalities, as well
as neurological disease.

Quantitative Real Time PCR Verification. To confirm gene expression results, we selected seven genes
from the differentially expressed gene list that were closely related to inflammatory response and immune modulation. A quantitative Real-Time PCR was performed using total RNA to validate the microarray data from the
same neonates studied by microarray analysis (Fig. 3). Of the seven selected differentially expressed genes, five
were down-regulated (GOS2, AREG, HBEGF, CAMP and LTF) and two were up-regulated (VNN2 and TRGV3).
Fold-changes obtained by RT-PCR were consistent with microarray results. All fold changes in RT-PCR results
reached significance (p ≤ 0.05) except for TRGV3 (p = 0.24). A comparison of the microarray data with RT-PCR
results is shown in Table 7.
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Gene Symbol

Gene name

Function

CCR2

C-C Motif Chemokine Receptor
2, Receptor for monocyte
chemoattractant protein-1

Role in asthma, inflammation

GIMAP4

GTPase, Immunity-Associated
Protein family member 4

T- and B-cell development and survival, T-cell apoptosis

KLRC3

Killer Cell Lectin-Like Receptor
Subfamily C, Member 3

Natural Killer receptor gene, role in cell proliferation

TRGV3

T Cell Receptor Gamma Variable 3

Peptide antigen binding, immune response

HRH2

Histamine Receptor H2

Histamine receptor gene, role in hypersensitiviy

CHRNA7

Cholinergic Receptor Nicotinic Alpha
Alter airway morphometry and lung function
7 Subunit

GIMAP7

GTPase, Immune-Associated
Nucleotide-Binding Protein 7

Regulators of lymphocyte survival and homeostasis
(Schwefel D 2013)

RTKN2

Rhotekin 2

Role in apoptosis

CD99

Cluster of differentiation 99, Singlechain type-1 glycoprotein

Role in cell adhesion, migration, death, differentiation
and diapedesis, and it influences processes associated
with inflammation, immune responses (pasello M 2018)

VNN2

Vanin 2

Hematopoietic cell trafficking, Role in oxidative-stress

PTEN

Phosphatase And Tensin Homolog

Role in asthma, hyper-reactivity

Table 3. Up-regulated genes after exposure to HCA and their functions.

Gene
symbol

Gene name

Function

PTGS2

Prostaglandin-Endoperoxide Synthase 2

Role in asthma and lung inflammation, hyperoxia induced
lung injury

GOS2

G0/G1 Switch 2

Regulation of lipid metabolism

AREG

Amphiregulin, Colorectum Cell-Derived Growth Factor

Role in asthma, airway modelling, BPD

HBEGF

Heparin-Binding Epidermal Growth Factor

Role in asthma, airway modelling

PLAUR

Plasminogen Activator, Urokinase Receptor

Role in asthma, COPD

CAMP

Cathelicidin Antimicrobial Peptide

Role in asthma, lung infection

NR4A3

Nuclear Receptor Subfamily 4 Group A Member 3

Regulates neutrolphils number and survival, Treg cell
development through activation of Foxp3

LTF

Lactotransferrin

Role in asthma, BPA VAP

FCAR

Fc Fragment Of Immunoglobulin Alpha Receptor

SNP associated with allergic asthma (Jasek M 2004)

NFIL3

Nuclear Factor, Interleukin 3 Regulated

Critical regulator for IgE production and airway hyperresponsiveness.

PDE4B

Phosphodiesterase 4B

Role in asthma, inhibitors use as treatment

ADGRE3

Adhesion G Protein-Coupled Receptor E3

Modulator of immune cell funtion

CXCL1

C-X-C Motif Chemokine Ligand 1

Role in BPD, lung alveolization

TARM1

T Cell-Interacting, Activating Receptor On Myeloid Cells 1

Upregulated by LPS, recruitment to site of inflammation

SNAI1

Snail Family Transcriptional Repressor 1

Β-catenin target gene, lung fibrosis

ZNF331

Zinc Finger Protein 331

Pathogenesis of asthma

ZC3H12A

Zinc Finger CCCH-Type Containing 12A

Regulates the development and function of IL-5-producing
TH2 cells through the Notch/Gata3 pathway

IRAK2

Interleukin 1 Receptor Associated Kinase 2

IRAK2 Attenuate the Proinflammatory Effects of IL-33 in
Asthma-like Mouse Models.

Table 4. Down-regulated genes after exposure to HCA and their functions.

Discussion

Histological chorioamnionitis is associated with significant long-term morbidities including asthma and allergic
and neurological disorders in preterm and term infants4–9. The exact mechanism of increased risk for asthma
and allergic disorders in neonates born to mothers with HCA is not well understood. Inflammatory mediators
released with HCA may reprogram the developing immune, respiratory, and neurological systems, leading to
allergy, asthma, and immunological and neurological disorders20,21. To our knowledge, this is the first study
reporting the differential gene expression profile in cord blood mononuclear leukocytes in term infants exposed
to HCA. Our data indicate that the key genes regulating inflammatory, immune, respiratory, and neurological
pathways are differentially expressed in cord blood leukocytes from term infants born to mothers with HCA.
Based on fold change, the top up-regulated genes included chemokine receptor CCR2, T-cell receptor gamma
variable-3 (TRGV3), and TRGV4. CCR2 is an important chemokine receptor that induces macrophage and
monocytes recruitment to sites of inflammation22. CCR2 is up-regulated on T-helper cells in an animal model of
allergic asthma and blocking of CCR2 suppressed airway inflammation18.The top down-regulated genes included
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Modified Functions

Number of Genes
Involved

Range of p-value
for genes involved

Cellular Movement

46

1.26E-13-1.52E-03

Immune Cell Trafficking

38

1.26E-13-1.03E-03

Inflammatory Disease

46

7.43E-13-1.25E-03

Cell Death and Survival

60

1.5E-12-1.46E-03

Immunological Disease

47

2.74E-12-1.25E-03

Connective Tissue Disorders

38

3.3E-12-1.47E-03

Inflammatory Response

55

3.55E-11-1.38E-03

Neurological Disease

32

1.29E-10-1.38E-03

Cell-To-Cell Signaling and Interaction

40

3.45E-10-1.51E-03

Hematological System Development and Function

44

3.45E-10-1.51E-03

Cellular Growth and Proliferation

49

2.3E-07-1.46E-03

Hematopoiesis

27

4.16E-07-9.74E-04

Lymphoid Tissue Structure and Development

33

4.16E-07-9.74E-04

Cellular Function and Maintenance

42

4.95E-07-1.52E-03

Humoral Immune Response

15

5.54E-07-1.4E-03

Infectious Diseases

28

6.5E-07-1.39E-03

Respiratory Disease

19

6.5E-07-1.23E-03

Cell Cycle

26

6.84E-07-1.49E-03

Gene Expression

37

6.84E-07-1.5E-03

Free Radical Scavenging

14

7.69E-06-9.02E-06

Cell-mediated Immune Response

15

2.3E-05-5.63E-04

DNA Replication, Recombination, and Repair

11

1.06E-04-4.46E-04

Antimicrobial Response

9

2.39E-04-2.39E-04

Nervous System Development and Function

15

3.11E-04-1.19E-03

Post-Translational Modification

14

3.43E-04-3.43E-04

Hypersensitivity Response

5

3.8E-04-3.8E-04

Hematological Disease

39

4.13E-04-1.09E-03

Cellular Assembly and Organization

6

8.04E-04-8.04E-04

Psychological Disorders

3

9.59E-04-9.59E-04

Respiratory System Development and Function

2

9.59E-04-9.59E-04

Developmental Disorder

12

1.24E-03-1.24E-03

Behavior

17

1.47E-03-1.47E-03

Table 5. Functions modified with exposure to HCA.

HBEGF, LTF, CAMP, and NR4A3. HBEGF is a potent vasodilator of intestinal microvasculature, and supplementation of HBEGF reduced intestinal injury in animal models of necrotizing enterocolitis (NEC)23–25.
In utero exposure to HCA leads to fetal inflammatory response syndrome. Understanding the effects of the
fetal inflammatory response on the programming of immune, respiratory, and neurological systems in neonates
could lead to new ways of modulating these responses and improving long-term consequences. We have identified several key genes involved in immune function, inflammation, and lung development that are expressed
differentially after exposure to HCA. These candidate genes are likely to play a critical role in long-term consequences including bronchopulmonary dysplasia (BPD), asthma, allergy, and immunological disorders in neonates exposed to HCA. This warrants further functional investigation.
We report that several important genes involved in the immune system are up-regulated in cord blood mononuclear cells after exposure to HCA. RTKN2 has anti-apoptotic properties, is highly expressed in T-cells, and
plays a role as a key signaling switch for regulation of genes involved in T-cell survival26. RTKN2 may prolong
survival of inflammatory cells and contribute to an exaggerated inflammatory response in neonates exposed to
HCA. CD99 is a cell surface protein involved in cell adhesion, migration, differentiation, and apoptosis, and influences processes associated with inflammation and immune response27. GIMAP family members play a role in
T-helper cell differentiation28. GIMAP4 and GIMAP5 have a role in T-cell survival. GIMAP7 is also a regulator of
lymphocyte survival and homeostasis29. NR4A3, a gene involved in protein coding that regulates Treg cell development through activation of FoxP3, and which may have potential for therapeutic target for immune disorders,
was down-regulated30. NR4A3 also positively regulates neutrophil survival and homeostasis31.
Our data indicate that several key pro-inflammatory mediators are down-regulated in cord blood mononuclear leukocytes after exposure to HCA. The down-regulation of a few pro-inflammatory mediators likely
is a modulating mechanism for the exaggerated inflammatory response induced by HCA. The inflammatory
mediators downregulated by HCA include PDE4B, CXCL1, TARM1, and IRAK2. PDE4B degrades cyclic AMP,
a second messenger involved in inflammatory process. Selective inhibition of PDE4B is a therapeutic target for
inflammatory and allergic disorders32. CXCL1 is a potent neutrophil chemoattractant that plays a role in the
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Ingenuity Canonical Pathways

−log10(p-value)

Molecules involved in pathways

Protein Kinase A Signaling

4.46

PTEN,PTGS2,PTPRE,DUSP6,MYH10, NFKBIE,PDE4B,ADD2,DUSP2,NFKBID

PI3K/AKT Signaling

3.32

PTEN,PTGS2,CDKN1A,NFKBIE,NFKBID

IL-17A Signaling in Airway Cells

3.12

PTEN,CXCL1,NFKBIE,NFKBID

MIF-mediated Glucocorticoid
Regulation

3.09

PTGS2,NFKBIE,NFKBID

MIF Regulation of Innate Immunity

2.83

PTGS2,NFKBIE,NFKBID

iCOS-iCOSL Signaling in T Helper
Cells

2.46

PTEN,HLA-DQB1,NFKBIE,NFKBID

TNFR2 Signaling

2

NFKBIE,NFKBID

IL-17 Signaling

1.99

PTGS2,CXCL1,TIMP1

4-1BB Signaling in T Lymphocytes

1.91

NFKBIE,NFKBID

IL-1 Signaling

1.9

NFKBIE,IRAK2,NFKBID

PPAR Signaling

1.9

PTGS2,NFKBIE,NFKBID

IL-17A Signaling in Fibroblasts

1.84

NFKBIE,NFKBID

B Cell Activating Factor Signaling

1.71

NFKBIE,NFKBID

IL-8 Signaling

1.7

HBEGF,PTGS2,CXCL1,IRAK2

p53 Signaling

1.68

PTEN,CDKN1A,TNFRSF10B

PI3K Signaling in B Lymphocytes

1.54

PTEN,NFKBIE,NFKBID

Glucocorticoid Receptor Signaling

1.49

CCNH,PTGS2,CDKN1A,NFKBIE,NFKBID

IL-10 Signaling

1.29

NFKBIE,NFKBID

T Helper Cell Differentiation

1.29

HLA-DQB1,IL23R

Table 6. Canonical pathways in ingenuity pathway analysis associated with differentially expressed genes
between control and HCA groups.
development of BPD33. IRAK2 forms a Myddosome complex with Myd88 and IRAK4, activating downstream
NF-kB and MAPKs P38 and JNK, leading to inflammatory response34. The roles of these pro-inflammatory mediators downregulated by exposure to HCA need further investigation.
We also report that several key genes involved in lung development, BPD, and asthma are expressed differentially
in cord blood mononuclear cells after exposure to HCA. Exposure to HCA upregulates CHRNA7, a key mediator
of the biological effects of nicotine. CHRNA7 plays a critical role in lung development as well in the pathogenesis of
asthma35,36, and inhibition of CHRNA7 is an important therapeutic target for asthma36. Amphiregulin (AREG) is a
member of the epidermal growth factor family and contributes to the regulation of cell proliferation. Recombinant
AREG suppresses epithelial cell apoptosis in LPS-induced lung injury in mice37. Down-regulation of AREG by HCA
may contribute to the development of BPD by increasing epithelial cell apoptosis. CAMP plays a critical role in
innate immunity against invasive bacterial infections. CAMP is an important host defense against respiratory pathogens. Suppression of CAMP by HCA may increase the risk for recurrent respiratory infections in neonates exposed
to HCA. Ramos-Martinez et al. showed that treatment with vitamin D reduced respiratory infections in patients
with asthma, and this effect was mediated by increase in CAMP38. LTF is an important mucosal antimicrobial protein that is also downregulated in neonates exposed to HCA. Revenis showed that the level of LTF was lower in tracheal aspirate samples from premature infants who developed BPD39. Additionally, LTF can down-regulate allergic
airway inflammation in asthma40. In an animal model of allergic rhinitis, LTF administration in the nostril alleviated
allergic rhinitis and its mechanisms41. NFIL3 is the most strongly induced transcription factor by IL-4 stimulation and is a critical regulator of IgE production and airway hyper-responsiveness42,43. The target genes (SNAI1,
ZNF331, Zc3h12a) for the canonical Wnt/B-catenin pathway are down-regulated after exposure to HCA. These
target genes of Wnt/B-catenin pathways play a role in the pathogenesis of asthma44–46. Peng et al. demonstrated that
Zc3h12a-knockout mice have severe spontaneous lung inflammation with an increase in IL-5- and IL-13-producing
cells in the lung45. ZNF331 was expressed differentially in bronchial alveolar lavage cells from patients with asthma46.
PTEN regulates airway smooth muscle contraction in allergic asthma47. Epithelial-mesenchymal transition (EMT)
accounts for accumulation of subepithelial mesenchymal cells and contributes to airway hyper-responsiveness and
remodeling48. Up-regulating expression of PTEN inhibits EMT and may be protective on airway modeling in asthma
and BPD. PTGS2/COX2 increases lung inflammation and impairs lung development33,49. HBEGF overexpression is
associated with airway remodeling and asthma50. Interestingly, we found that expression of PTGS2 and HBEGF was
down-regulated in cord blood mononuclear cells after exposure to HCA. HBEGF was also downregulated in lung
tissue after intra-amniotic LPS administration in an animal model of HCA51. The role of PTGS2 and HBEGF on lung
development and lung inflammation needs further investigation.
Infants and children born to mothers with HCA are at not only an increased risk for development of inflammatory, immune, and allergic diseases, but they are also predisposed to abnormal neurodevelopmental disorders7–9.
Our pathway analysis indicates that exposure to HCA affects genes involved in nervous system development,
neurological disease, behavioral, developmental, and psychological disorders. Allard et al. showed that female rats
exposed to in utero placental inflammation showed hyperactive behavior after puberty52. IPA analysis of our data
indicates that HCA differentially expressed genes in the IL-17 signaling pathway, IL-17A signaling in airway cells,
and IL-17A signaling in fibroblasts. Recent findings suggests that IL-17A in the fetal and maternal inflammatory
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Figure 1. Ingenuity pathway analysis networks related to immune modulation and inflammatory response
are presented in this figure (A–D). Pathway analysis was performed using Ingenuity Pathway Analysis (IPA)
software (QIAGEN Inc., https://www.qiagenbioinformatics.com/products/ingenuitypathway-analysis) by
loading 366 probe sets that were differentially expressed with HCA19.
response leads to fetal brain injury and neurological sequelae including cerebral palsy and potentially autism,
schizophrenia, and multiple sclerosis later in life53.
Our study has several strengths. This is the first study reporting differential gene expression in cord blood
from term neonates exposed to HCA. A similar study reported differential gene expression after exposure to HCA
in preterm infants using whole blood, which does not allow distinction of the relative contribution of leukocytes.
Our study is unique as global gene expression was performed in cord blood mononuclear leukocytes, not in
whole blood. Further, our global gene expression data were validated by Real-Time PCR for the identified target
genes. Six out of seven genes validated with Real-Time PCR showed significant change in the same direction as
microarray data, with the seventh gene displaying trends in the same direction. Neonates are vulnerable subjects,
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Figure 2. Ingenuity pathway analysis networks related to neurological disease are presented in this figure
(A,B). Pathway analysis was performed using Ingenuity Pathway Analysis (IPA) software (QIAGEN Inc.,
https://www.qiagenbioinformatics.com/products/ingenuitypathway-analysis) by loading 366 probe sets that
were differentially expressed with HCA19.

and drawing a large amount of blood from them is ethically unacceptable. By using umbilical cord blood, we were
able to collect a large amount of blood non-invasively without additional risks to the neonates.
Our study also has several limitations. Our sample size of 10 neonates is small, but similar sample sizes have
been used commonly in studies investigating differential gene expression using microarray12,54. There is an inherent chance of finding differences in the gene expression due to multiple comparison; however, our results were
validated by using Real-Time PCR.
In conclusion, HCA induces differential gene expression in cord blood mononuclear leukocytes from term
neonates. We found novel genes and pathways associated with exposure to HCA, including key genes regulating
inflammatory, immune, respiratory and neurological pathways. This differential gene expression may contribute to
inflammatory, immunological, and neurological disorders in neonates exposed to HCA. Future studies can further
validate differential expression of target genes in a larger cohort of neonates exposed to HCA. Our data may lead to
understanding the role of key genes and pathways identified in this study on the long-term sequelae related to exposure to HCA. Functional studies on the identified genes and pathways could lead to the development of potential
markers for the diseases caused by exposure to HCA and possible therapy to prevent those complications.

Methods

Ethical approval: human study protocol and institutional biosafety approvals. All human proto-

cols and procedures described in this study were approved by the Institutional Review Board of Thomas Jefferson
University Hospital. All experiments performed in this study were approved and in accordance with the Nemours
Institutional Biosafety Committee. The Institutional Review Board waived informed consent as this study was
performed on discarded blood and placental tissue samples.

Study Design.

This is a prospective observational study that examines differential gene expression in mononuclear leukocytes isolated from cord blood of term infants born to mothers with HCA. Cord blood and fetal
membranes were collected from term neonates (37–40 weeks of gestation). Exclusion criteria were maternal
infections other than HCA and complications of pregnancy including diabetes, hypertension, major congenital/
chromosomal anomalies, and intrauterine growth restriction.
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Figure 3. Box plot for real-time PCR data on selected genes in the two groups (Control and HCA) are
presented in this figure.

Cord blood collection and isolation of leukocytes. At the time of delivery, the umbilical cord was
disinfected and cut at the placental side of the clamp. Cord blood was collected in sterile EDTA tubes, mixed thoroughly, and checked for blood clots. Mononuclear leukocytes were isolated by Ficoll-Paque Plus density gradient
(GE Healthcare Biosciences, Pittsburgh, PA), following the manufacturer’s protocol and the method of Normann
et al.55. In brief, collected blood was diluted with an equal amount of phosphate buffered saline (PBS). 1 ml of
PBS was mixed thoroughly with 16 ml of Ficoll-Paque plus and used as density gradient. 25 to 30 ml of diluted
blood was layered on top of the Ficoll mixture and centrifuged at 400xg for 30 minutes. The upper plasma layer
was collected and centrifuged to remove platelets. The cellular interface was then collected in a separate tube and
washed with PBS containing 1 mM EDTA. Cells were washed with autologous plasma to remove platelets. Finally,
the mononuclear leukocytes were washed with PBS, and 2 million packed cells per vial were saved at −80 °C for
RNA isolation and microarray analysis.
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Microarray

Real-Time PCR

Gene Symbol

Fold Change

p-value

Fold Change

p-value

GOS2

−3.18

0.011

−6.42

0.015

AREG

−2.54

0.006

−4.78

0.007

HBEGF

−2.15

0.008

−3.53

0.005

CAMP

−1.83

0.005

−2.93

0.023

LTF

−1.73

0.044

−2.56

0.042

VNN2

1.56

0.021

1.55

0.028

TRGV3

1.78

9.18E-04

3.67

0.240*

Table 7. Validation of microarray data with real-time PCR.

Fetal membrane collection, processing, staining, and diagnosis of HCA.

Small pieces of fetal
membranes tissue were washed with cold PBS and fixed in 10% neutral buffered formalin for 24–48 hours.
Membrane pieces were processed and paraffin embedded in Histoplast LP (Thermo Fisher Scientific, Fremont,
CA). Samples were sectioned at 5 µm on a Leica RM2255 microtome (Leica, Buffalo Grove, IL) and floated onto
Superfrost Plus slides (Thermo Fisher Scientific, Fremont, CA). The sections were heat immobilized for 60 minutes at 60 °C and were subsequently equilibrated to room temperature prior to staining. The slides were placed on
Tissue-Tek Prizma stainer (Sakura Finetek USA, Torrance, CA) and were deparaffinized with xylene, hydrated
through a graded series of alcohols, and hydrated to water. Finally, the slides were stained with Harris hematoxylin (BBC Biomedical, Mount Vernon, WA) and eosin (Acros Organics, Cole-Parmer, Vernon Hills, IL) and were
dehydrated, cleared, and mounted in Permount (Thermo Fisher Scientific, Fremont, CA). Tissue samples were
processed by the Nemours Histochemistry and Tissue Processing Core using standard workflows and operating
procedures. The stained slides were examined by a pathologist (JC) and classified either as HCA (placental membranes score ≥ stage 1) or no HCA (no histological inflammatory changes in fetal membranes)56.

®

®

RNA Isolation and Gene Expression Study.

Total RNA was isolated using Qiagen miRNeasy Mini Kit
(Qiagen, Germantown, MD). RNA was quantified on a Nanodrop ND-2000 spectrophotometer (Thermo Fisher
Scientific, Waltham, MA), and quality was assessed by an Agilent 2200 TapeStation (Agilent Technologies, Palo
Alto, CA). 100 ng of RNA was used from each sample to prepare fragmented biotin-labeled cDNA by GeneChip
WT PLUS reagent kit (Affymetrix, Santa Clara, CA). The Affymetrix gene chips and Human Transcriptome Array
2.0 were hybridized with 5 µg of fragmented biotin-labeled cDNA in 220 µl hybridization cocktail, followed by
target denaturation at 99 °C for 5 min and then 45 °C for 5 min. Hybridization was performed for 16 hours at 45 °C
with a rotation of 60 rpm. An Affymetrix GeneChip hybridization wash and stain kit was used to wash and stain
the arrays in GeneChip Fluidic Station 450. Chips were scanned on an Affymetrix GeneChip Scanner 3000 using
Command Console Software (Thermo Fisher Scientific, Waltham, MA). Expression Console Software v1.4.1 was
used to perform quality control.

Real-Time PCR. Selected genes from microarray data were validated by Quantitative Real Time PCR with
TaqMan Gene Expression Assay Mix from Applied Biosystems (Applied Biosystems, Foster City, CA) following
the manufacturer’s protocol. In brief, 200 ng of total RNA was reverse transcribed with a High-Capacity cDNA
RT kit (Applied Biosystems, Foster City, CA) in a total reaction volume of 20 µl. Real-Time PCR was performed
in duplicate wells with 0.5 µl of cDNA preparation using TaqMan Universal PCR Master Mix and TaqMan Gene
Expression Assay mixes specific for different genes. Actin B was used as a housekeeping gene, and data were collected by Quant Studio 12K Flex Thermal Cycler (Applied Biosystems, Foster City, CA).
Statistical Analysis.

Expression Console Software was used to generate a Chp file from Affymetrix after
sst-rma normalization. The HCA Group was compared with the control group using Transcriptome array console
software v 1.4.1 (Thermo Fisher Scientific, Waltham, MA). Genes with fold change ≥1.5 and p < 0.05 were identified as differentially expressed. Student t-test was performed for comparison of the two groups. Gene expression data are available at the Gene Expression Omnibus (GEO) database of the NIH under accession number
GSE120855. Data were analyzed through the use of IPA (QIAGEN Inc., https://www.qiagenbioinformatics.com/
products/ingenuitypathway-analysis)19. Real-Time data were compared using Student t-test or Wilcoxon signed
rank test between the HCA and control group.
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